How long should we continue S-1 as adjuvant chemotherapy for squamous cell carcinoma of the head and neck?
Hirai M, Orita Y, Takao S, Tachibana T, Marunaka H, Makihara S, Miki K, Noyama Y, Fuji S, Torigoe A, Sato Y, Nishizaki K.
Hirai M, et al. Among authors: makihara s.
Acta Otolaryngol. 2015;135(10):1079-85. doi: 10.3109/00016489.2015.1049664. Epub 2015 May 25.
Acta Otolaryngol. 2015.
PMID: 26004393
Clinical Trial.